Valeant Pharms Intl Drug Patent Portfolio
Valeant Pharms Intl owns 2 orange book drugs protected by 7 US patents Given below is the list of Valeant Pharms Intl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8497256 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males | 23 Jun, 2031 | Active |
| US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | 24 Feb, 2027 | Active |
| US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | 24 Feb, 2027 | Active |
| US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | 24 Aug, 2026 | Active |
| US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | 24 Aug, 2026 | Active |
| US9192616 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives | 02 Aug, 2026 | Active |
| US6197341 | Formulations of balsalazide and its derivatives | 13 Mar, 2018 | Expired |
Latest Legal Activities on Valeant Pharms Intl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Valeant Pharms Intl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Apr, 2023 | US9192616 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 May, 2021 | US7625884 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 May, 2021 | US7625884 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 Jan, 2021 | US8497256 (Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 27 Apr, 2020 | US7452872 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 27 Apr, 2020 | US7452872 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 May, 2019 | US9192616 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 11 May, 2017 | US7625884 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 11 May, 2017 | US7625884 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 03 May, 2016 | US7452872 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 03 May, 2016 | US7452872 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 24 Nov, 2015 | US9192616 |
|
Recordation of Patent Grant Mailed
Critical
| 24 Nov, 2015 | US9192616 |
|
Email Notification
Critical
| 05 Nov, 2015 | US9192616 |
|
Issue Notification Mailed
Critical
| 04 Nov, 2015 | US9192616 |
Valeant Pharms Intl's Family Patents
Valeant Pharms Intl Drug List
Given below is the complete list of Valeant Pharms Intl's drugs and the patents protecting them.
1. Colazal
Colazal is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7452872
(Pediatric)
| Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Feb, 2027
(2 years from now)
| Active |
| US7625884
(Pediatric)
| Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Feb, 2027
(2 years from now)
| Active |
| US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Aug, 2026
(1 year, 8 months from now)
| Active |
| US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Aug, 2026
(1 year, 8 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Colazal's drug page
2. Giazo
Giazo is protected by 5 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8497256 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
23 Jun, 2031
(6 years from now)
| Active |
| US7452872 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Aug, 2026
(1 year, 8 months from now)
| Active |
| US7625884 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
24 Aug, 2026
(1 year, 8 months from now)
| Active |
| US9192616 | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
02 Aug, 2026
(1 year, 7 months from now)
| Active |
| US6197341 | Formulations of balsalazide and its derivatives |
13 Mar, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Giazo's drug page